BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 337 filers reported holding BIONTECH SE in Q3 2021. The put-call ratio across all filers is 1.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,154 | -6.1% | 10,619 | -6.7% | 0.00% | -33.3% |
| Q2 2023 | $1,229 | -15.2% | 11,385 | -2.2% | 0.00% | 0.0% |
| Q1 2023 | $1,450 | +14.4% | 11,640 | +38.0% | 0.00% | 0.0% |
| Q4 2022 | $1,267 | -99.9% | 8,437 | -36.3% | 0.00% | -40.0% |
| Q3 2022 | $1,787,000 | +162.4% | 13,253 | +190.1% | 0.01% | +150.0% |
| Q2 2022 | $681,000 | -20.7% | 4,569 | -9.3% | 0.00% | 0.0% |
| Q1 2022 | $859,000 | -51.7% | 5,038 | -26.9% | 0.00% | -50.0% |
| Q4 2021 | $1,777,000 | -17.6% | 6,895 | -12.8% | 0.00% | -20.0% |
| Q3 2021 | $2,157,000 | +19.8% | 7,903 | -1.7% | 0.01% | 0.0% |
| Q2 2021 | $1,800,000 | +92.5% | 8,042 | -6.2% | 0.01% | +66.7% |
| Q1 2021 | $935,000 | +47.2% | 8,570 | +9.9% | 0.00% | +50.0% |
| Q4 2020 | $635,000 | +64.9% | 7,801 | +40.2% | 0.00% | +100.0% |
| Q3 2020 | $385,000 | – | 5,563 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $22,333,808 | 17.21% |
| Quinn Opportunity Partners LLC | 262,071 | $39,368,306 | 4.82% |
| Temasek Holdings (Private) Ltd | 4,378,022 | $657,666,465 | 3.84% |
| PARUS FINANCE (UK) Ltd | 29,988 | $4,504,797 | 3.06% |
| Top Ace Asset Management Ltd | 20,000 | $3,004,400 | 2.21% |
| Artia Global Partners LP | 37,108 | $5,574,364 | 2.12% |
| Boston Common Asset Management, LLC | 269,803 | $40,530 | 1.94% |
| FLOSSBACH VON STORCH AG | 3,282,723 | $493,130,649 | 1.88% |
| Redwood Investments, LLC | 87,540 | $13,150,259 | 1.76% |
| Baader Bank Aktiengesellschaft | 238,800 | $35,881,130 | 1.74% |